The long term objectives of this application are to better
understand the cellular events taking place during the process of
bone remodeling. This process is sequential and involves a number
of steps and a number of cell types. Among these cell types, the
osteoclast is the cell responsible for the extracellular resorption
of the bone matrix. This cell is also potentially involved, directly
or via its precursors, in the recognition of the matrix to resorb.
Similarly, the osteoclasts or their activity if potentially involved
in the local activation of bone formation.
Most diseases of the skeleton, whether metabolic (osteoporosis,
renal osteodystrophy), inherited (osteopetrosis, osteogenesis
imperfecta), infectious (Paget, periodontal disease, osteoarthritis)
or tumoral in nature, involve an abnormality in the bone
remodeling sequence. The osteoclasts playing such an essential
role in this process, our research program focuses on the cell and
molecular biology of the osteoclast's function and differentiation.
The specific aims of this application are:
1/ to further characterize the plasma membrane of the mature
osteoclast at the molecular level by:
a) further determining the role of the (Na+,K+) ATPase subunits
in bone resorption, and
b) generating new monoclonal and monospecific polyclonal
antibodies, to further investigate the function of this cell.
2/ To better understand the biology of the osteoclast at the
cellular level and in particular:
a) The mechanisms by which lysosomal enzymes and other
potential secretory protein(s) are targeted to the ruffled border
membrane:
b) The differences between the apical (ruffled-border) and baso-
lateral membranes;
c) The mechanisms by which the polarity of this cell is
established and maintained;
d) The role of other ion transport proteins in the mechanisms of
the bone resorption.
3/ Further compare the osteoclast to other cells involved in
transport and acidification (Gastric parietal cell, renal tubule,
hepatocyte)
4/ Further analyse the effects of calcium regulating hormones on
the distribution, expression and function of the abovementioned
molecules and/or mechanisms in which they are involved.
The experimental approach selected in this project involves both
in vivo and in vitro studies, at the organ, cellular and subcellular
levels and in various species (chicken, rat, rabbit). The methods
of procedure include the purification and culture of osteoclasts,
the fractionation of their membranes, the development of
monoclonal and polyclonal antibodies, the analysis of membrane
proteins by SDS-PAGE and immunochemical methods,
immunocytochemistry at the light and electron microscopic
levels, and the in situ hybridization of selected probes.
National Institute of Dental and Craniofacial Research
CFDA Code
DUNS Number
043207562
UEI
FL6GV84CKN57
Project Start Date
01-August-1977
Project End Date
30-November-1992
Budget Start Date
15-December-1990
Budget End Date
30-November-1991
Project Funding Information for 1991
Total Funding
$288,172
Direct Costs
$171,531
Indirect Costs
$116,641
Year
Funding IC
FY Total Cost by IC
1991
National Institute of Dental and Craniofacial Research
$288,172
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01DE004724-13
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01DE004724-13
Patents
No Patents information available for 5R01DE004724-13
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01DE004724-13
Clinical Studies
No Clinical Studies information available for 5R01DE004724-13
News and More
Related News Releases
No news release information available for 5R01DE004724-13
History
No Historical information available for 5R01DE004724-13
Similar Projects
No Similar Projects information available for 5R01DE004724-13